Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00096226

Public ClinicalTrials.gov record NCT00096226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 7:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial Of Neoadjuvant Therapy With Concurrent Chemotherapy And High Dose Radiotherapy Followed By Surgical Resection And Consolidative Therapy For Locally Advanced Non-Small Cell Lung Carcinoma

Study identification

NCT ID
NCT00096226
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Radiation Therapy Oncology Group
Network
Enrollment
60 participants

Conditions and interventions

Conditions

Interventions

  • Induction Carboplatin Drug
  • Induction Paclitaxel Drug
  • Resection Procedure
  • Consolidation Carboplatin Drug
  • Radiation Therapy Radiation
  • Consolidation Paclitaxel Drug

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Mar 31, 2012
Completion
May 15, 2016
Last update posted
Sep 17, 2019

2004 – 2016

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Arizona Oncology Services Foundation Phoenix Arizona 85013
Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea Scottsdale Arizona 85260
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181
Mayo Clinic - Jacksonville Jacksonville Florida 32224
Tallahassee Memorial Hospital Tallahassee Florida 32308
Cancer Institute at St. John's Hospital Springfield Illinois 62702
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201
Saint Joseph Mercy Cancer Center Ann Arbor Michigan 48106-0995
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106
Mayo Clinic Cancer Center Rochester Minnesota 55905
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110
Methodist Estabrook Cancer Center Omaha Nebraska 68114
Cancer Institute of New Jersey at Cooper University Hospital - Camden Camden New Jersey 08103
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043
Leo W. Jenkins Cancer Center at ECU Medical School Greenville North Carolina 27835-6028
St. Luke's Cancer Network at St. Luke's Hospital Bethlehem Pennsylvania 18015
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425
Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center Kingsport Tennessee 37662
Schiffler Cancer Center at Wheeling Hospital Wheeling West Virginia 26003
St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54307-3508
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226
Veterans Affairs Medical Center - Milwaukee Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00096226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2019 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00096226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →